サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1701259

免疫測定分析装置の市場規模、シェア、動向分析レポート：製品別、用途別、最終用途別、地域別、セグメント予測、2025年～2030年

Immunoassay Analyzers Market Size, Share & Trends Analysis Report By Product (Chemiluminescence Immunoassays, Fluorescence Immunoassay, Radioimmunoassay), By Application (Oncology, Cardiology), By End-use, By Region And Segment Forecasts, 2025 - 2030

出版日
ページ情報
英文 150 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
免疫測定分析装置の市場規模、シェア、動向分析レポート：製品別、用途別、最終用途別、地域別、セグメント予測、2025年～2030年
出版日: 2025年03月11日
発行: Grand View Research
ページ情報: 英文 150 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

免疫測定分析装置の市場動向：

免疫測定分析装置の世界市場規模は2024年に71億8,000万米ドルと推定され、2025年から2030年にかけてCAGR 4.13%で成長すると予測されます。

感染症および非感染症を含む慢性疾患の増加は、免疫測定分析装置市場成長の重要な促進要因です。がんや心血管疾患などの疾病の負担が増加の一途をたどるなか、技術的進歩やイムノアッセイ分析装置の応用は急速に拡大しています。これらの進歩は、早期診断、疾患のモニタリング、治療計画において重要な役割を果たしています。世界保健機関（WHO）は、2022年に約2,000万人が新たにがんに罹患すると報告しており、今後数年間で診断件数は5,350万件に達すると予測されています。このような慢性疾患の急増は、革新的なイムノアッセイ・ソリューションの需要に拍車をかけており、主要企業はより高度で効果的な診断技術の開発に取り組んでいます。

COVID-19パンデミックの発生は、迅速で正確な診断ツールの必要性をさらに強調しました。SARS-CoV-2ウイルスの出現は、精度と手頃な価格の両方を提供できる加速診断法に対する緊急の需要を生み出しました。RT-PCR検査は早期発見のために広く使用されていたが、高価でリソースを必要とすることが多くなりました。そのため、抗体を検出するイムノアッセイ分析装置が広く導入されるようになり、より費用対効果が高く効率的な代替手段が提供されるようになりました。各社はこの需要に迅速に対応し、先進的なイムノアッセイ・ソリューションを発表しました。例えば、Agilent Technologies, Inc.は、ヒト血清または血漿中のSARS-CoV-2抗体を検出するために設計されたAgilent Dako SARS-CoV-2酵素結合イムノアッセイキットを発表しました。パンデミックはイムノアッセイ分析装置の機能に対する認識を高め、技術開発と市場開拓を加速させました。

慢性疾患の増加は免疫測定技術の継続的な進歩を促しました。新たな感染症の出現、抗生物質耐性に対する懸念の高まり、個別化医療に対する需要の高まりが、高感度、特異的、迅速なイムノアッセイ検査の必要性に拍車をかけています。様々な企業が、こうした進化するヘルスケアニーズに対応するため、革新的なソリューションに投資しています。例えばDiamond Diagnostics社は、免疫測定分析装置用の高品質で費用対効果の高い消耗品やアクセサリーを製造することで、免疫測定診断の強化に取り組んでいます。このような技術革新は、医療従事者が信頼性の高い高度な診断ツールを利用できるようにし、市場の拡大に貢献しています。

技術的進歩に加え、主要企業間の戦略的提携も市場成長に大きく寄与しています。各社は、イムノアッセイ能力の強化、治療法の進歩のサポート、臨床採用の促進を目的とした提携を結ぶケースが増えています。注目すべき例として、2023年7月にBeckman Coulter, Inc.と富士レビオが提携したことが挙げられます。この提携は、神経変性疾患研究、臨床試験、ルーチン診断、償還プロセスにおける免疫測定アプリケーションを強化することを目的としています。専門知識とリソースを組み合わせることで、これらの提携はイノベーションを推進し、高度な診断ソリューションの利用しやすさを向上させています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 免疫測定分析装置の市場変数、動向、範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随市場見通し
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • 免疫測定分析装置市場分析ツール
    • 業界分析- ポーターのファイブフォース分析
    • PESTEL分析
  • ケーススタディ

第4章 免疫測定分析装置市場：製品の推定・動向分析

  • 市場シェア、2024年および2030年
  • セグメントダッシュボード
  • 市場の変動分析
  • 市場規模と動向分析、2018～2030年
  • 化学発光免疫測定（CLIA）
  • 蛍光免疫測定（FIA）
  • ラジオイムノアッセイ
  • 酵素免疫測定
  • v消耗品とアクセサリ
  • 消耗品とアクセサリー

第5章 免疫測定分析装置市場：用途の推定・動向分析

  • 市場シェア、2024年および2030年
  • セグメントダッシュボード
  • 市場の変動分析
  • 市場規模と動向分析、2018～2030年
  • 治療薬物モニタリング
  • 腫瘍学
  • 心臓病学
  • 内分泌学
  • 感染症検査
  • 自己免疫疾患
  • その他

第6章 免疫測定分析装置市場：最終用途の推定・動向分析

  • 市場シェア、2024年および2030年
  • セグメントダッシュボード
  • 市場の変動分析
  • 市場規模と動向分析、2018～2030年
  • 病院と診療所
  • 診断検査室
  • 調査機関

第7章 免疫測定分析装置市場：地域の推定・動向分析

  • 地域別市場シェア分析、2024年および2030年
  • 地域市場ダッシュボード
  • 世界地域市場のスナップショット
  • 市場規模、予測動向分析、2018年から2030年まで：
  • 北米
    • 北米： SWOT分析
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 欧州： SWOT分析
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • ノルウェー
    • スウェーデン
    • デンマーク
  • アジア太平洋
    • アジア太平洋地域： SWOT分析
    • 日本
    • 中国
    • インド
    • オーストラリア
    • 韓国
    • タイ
  • ラテンアメリカ
    • ラテンアメリカ： SWOT分析
    • ブラジル
    • アルゼンチン
  • 中東・アフリカ
    • MEA：SWOT分析
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第8章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 企業/競合の分類
  • ベンダー情勢
    • 主要販売代理店およびチャネルパートナーのリスト
    • 主要顧客
    • 主要企業の市場シェア分析（2024年）
    • Siemens Healthineers AG
    • BIOMERIEUX
    • FAbbott
    • QuidelOrtho Corporation
    • Sysmex Corporation
    • BD
    • Thermo Fisher Scientific Inc.
    • F. Hoffmann-La Roche Ltd
    • Beckman Coulter, Inc.
    • DiaSorin SpA
図表

List of Tables

  • Table 1 List of abbreviations
  • Table 2 North America immunoassay analyzers market, by region, 2018 - 2030 (USD Million)
  • Table 3 North America immunoassay analyzers market, by product, 2018 - 2030 (USD Million)
  • Table 4 North America immunoassay analyzers market, by application, 2018 - 2030 (USD Million)
  • Table 5 North America immunoassay analyzers market, by end use, 2018 - 2030 (USD Million)
  • Table 6 U.S. immunoassay analyzers market, by product, 2018 - 2030 (USD Million)
  • Table 7 U.S. immunoassay analyzers market, by application, 2018 - 2030 (USD Million)
  • Table 8 U.S. immunoassay analyzers market, by end use, 2018 - 2030 (USD Million)
  • Table 9 Canada immunoassay analyzers market, by product, 2018 - 2030 (USD Million)
  • Table 10 Canada immunoassay analyzers market, by application, 2018 - 2030 (USD Million)
  • Table 11 Canada immunoassay analyzers market, by end use, 2018 - 2030 (USD Million)
  • Table 12 Mexico immunoassay analyzers market, by product, 2018 - 2030 (USD Million)
  • Table 13 Mexico immunoassay analyzers market, by application, 2018 - 2030 (USD Million)
  • Table 14 Mexico immunoassay analyzers market, by end use, 2018 - 2030 (USD Million)
  • Table 15 Europe immunoassay analyzers market, by region, 2018 - 2030 (USD Million)
  • Table 16 Europe immunoassay analyzers market, by product, 2018 - 2030 (USD Million)
  • Table 17 Europe immunoassay analyzers market, by application, 2018 - 2030 (USD Million)
  • Table 18 Europe immunoassay analyzers market, by end use, 2018 - 2030 (USD Million)
  • Table 19 Germany immunoassay analyzers market, by product, 2018 - 2030 (USD Million)
  • Table 20 Germany immunoassay analyzers market, by application, 2018 - 2030 (USD Million)
  • Table 21 Germany immunoassay analyzers market, by end use, 2018 - 2030 (USD Million)
  • Table 22 UK immunoassay analyzers market, by product, 2018 - 2030 (USD Million)
  • Table 23 UK immunoassay analyzers market, by application, 2018 - 2030 (USD Million)
  • Table 24 UK immunoassay analyzers market, by end use, 2018 - 2030 (USD Million)
  • Table 25 France immunoassay analyzers market, by product, 2018 - 2030 (USD Million)
  • Table 26 France immunoassay analyzers market, by application, 2018 - 2030 (USD Million)
  • Table 27 France immunoassay analyzers market, by end use, 2018 - 2030 (USD Million)
  • Table 28 Italy immunoassay analyzers market, by product, 2018 - 2030 (USD Million)
  • Table 29 Italy immunoassay analyzers market, by application, 2018 - 2030 (USD Million)
  • Table 30 Italy immunoassay analyzers market, by end use, 2018 - 2030 (USD Million)
  • Table 31 Spain immunoassay analyzers market, by product, 2018 - 2030 (USD Million)
  • Table 32 Spain immunoassay analyzers market, by application, 2018 - 2030 (USD Million)
  • Table 33 Spain immunoassay analyzers market, by end use, 2018 - 2030 (USD Million)
  • Table 34 Denmark immunoassay analyzers market, by product, 2018 - 2030 (USD Million)
  • Table 35 Denmark immunoassay analyzers market, by application, 2018 - 2030 (USD Million)
  • Table 36 Denmark immunoassay analyzers market, by end use, 2018 - 2030 (USD Million)
  • Table 37 Sweden immunoassay analyzers market, by product, 2018 - 2030 (USD Million)
  • Table 38 Sweden immunoassay analyzers market, by application, 2018 - 2030 (USD Million)
  • Table 39 Sweden immunoassay analyzers market, by end use, 2018 - 2030 (USD Million)
  • Table 40 Norway immunoassay analyzers market, by product, 2018 - 2030 (USD Million)
  • Table 41 Norway immunoassay analyzers market, by application, 2018 - 2030 (USD Million)
  • Table 42 Norway immunoassay analyzers market, by end use, 2018 - 2030 (USD Million)
  • Table 43 Asia Pacific immunoassay analyzers market, by region, 2018 - 2030 (USD Million)
  • Table 44 Asia Pacific immunoassay analyzers market, by product, 2018 - 2030 (USD Million)
  • Table 45 Asia Pacific immunoassay analyzers market, by application, 2018 - 2030 (USD Million)
  • Table 46 Asia Pacific immunoassay analyzers market, by end use, 2018 - 2030 (USD Million)
  • Table 47 China immunoassay analyzers market, by product, 2018 - 2030 (USD Million)
  • Table 48 China immunoassay analyzers market, by application, 2018 - 2030 (USD Million)
  • Table 49 China immunoassay analyzers market, by end use, 2018 - 2030 (USD Million)
  • Table 50 Japan immunoassay analyzers market, by product, 2018 - 2030 (USD Million)
  • Table 51 Japan immunoassay analyzers market, by application, 2018 - 2030 (USD Million)
  • Table 52 Japan immunoassay analyzers market, by end use, 2018 - 2030 (USD Million)
  • Table 53 India immunoassay analyzers market, by product, 2018 - 2030 (USD Million)
  • Table 54 India immunoassay analyzers market, by application, 2018 - 2030 (USD Million)
  • Table 55 India immunoassay analyzers market, by end use, 2018 - 2030 (USD Million)
  • Table 56 South Korea immunoassay analyzers market, by product, 2018 - 2030 (USD Million)
  • Table 57 South Korea immunoassay analyzers market, by application, 2018 - 2030 (USD Million)
  • Table 58 South Korea immunoassay analyzers market, by end use, 2018 - 2030 (USD Million)
  • Table 59 Australia immunoassay analyzers market, by product, 2018 - 2030 (USD Million)
  • Table 60 Australia immunoassay analyzers market, by application, 2018 - 2030 (USD Million)
  • Table 61 Australia immunoassay analyzers market, by end use, 2018 - 2030 (USD Million)
  • Table 62 Thailand immunoassay analyzers market, by product, 2018 - 2030 (USD Million)
  • Table 63 Thailand immunoassay analyzers market, by application, 2018 - 2030 (USD Million)
  • Table 64 Thailand immunoassay analyzers market, by end use, 2018 - 2030 (USD Million)
  • Table 65 Latin America immunoassay analyzers market, by product, 2018 - 2030 (USD Million)
  • Table 66 Latin America immunoassay analyzers market, by application, 2018 - 2030 (USD Million)
  • Table 67 Latin America immunoassay analyzers market, by end use, 2018 - 2030 (USD Million)
  • Table 68 Brazil immunoassay analyzers market, by product, 2018 - 2030 (USD Million)
  • Table 69 Brazil immunoassay analyzers market, by application, 2018 - 2030 (USD Million)
  • Table 70 Brazil immunoassay analyzers market, by end use, 2018 - 2030 (USD Million)
  • Table 71 Argentina immunoassay analyzers market, by product, 2018 - 2030 (USD Million)
  • Table 72 Argentina immunoassay analyzers market, by application, 2018 - 2030 (USD Million)
  • Table 73 Argentina immunoassay analyzers market, by end use, 2018 - 2030 (USD Million)
  • Table 74 MEA immunoassay analyzers market, by region, 2018 - 2030 (USD Million)
  • Table 75 MEA immunoassay analyzers market, by product, 2018 - 2030 (USD Million)
  • Table 76 MEA immunoassay analyzers market, by application, 2018 - 2030 (USD Million)
  • Table 77 MEA immunoassay analyzers market, by end use, 2018 - 2030 (USD Million)
  • Table 78 South Africa immunoassay analyzers market, by product, 2018 - 2030 (USD Million)
  • Table 79 South Africa immunoassay analyzers market, by application, 2018 - 2030 (USD Million)
  • Table 80 South Africa immunoassay analyzers market, by end use, 2018 - 2030 (USD Million)
  • Table 81 Saudi Arabia immunoassay analyzers market, by product, 2018 - 2030 (USD Million)
  • Table 82 Saudi Arabia immunoassay analyzers market, by application, 2018 - 2030 (USD Million)
  • Table 83 Saudi Arabia immunoassay analyzers market, by end use, 2018 - 2030 (USD Million)
  • Table 84 UAE immunoassay analyzers market, by product, 2018 - 2030 (USD Million)
  • Table 85 UAE immunoassay analyzers market, by application, 2018 - 2030 (USD Million)
  • Table 86 UAE immunoassay analyzers market, by end use, 2018 - 2030 (USD Million)
  • Table 87 Kuwait immunoassay analyzers market, by product, 2018 - 2030 (USD Million)
  • Table 88 Kuwait immunoassay analyzers market, by application, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in APAC
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value-chain-based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 Immunoassay analyzers market: market outlook
  • Fig. 14 Immunoassay analyzers competitive insights
  • Fig. 15 Parent market outlook
  • Fig. 16 Related/ancillary market outlook
  • Fig. 17 Penetration and growth prospect mapping
  • Fig. 18 Industry value chain analysis
  • Fig. 19 Immunoassay analyzers market driver impact
  • Fig. 20 Immunoassay analyzers market restraint impact
  • Fig. 21 Immunoassay analyzers market strategic initiatives analysis
  • Fig. 22 Immunoassay analyzers market: Product movement analysis
  • Fig. 23 Immunoassay analyzers market: Product outlook and key takeaways
  • Fig. 24 Chemiluminescence Immunoassays (CLIA) market estimates and forecast, 2018 - 2030
  • Fig. 25 Fluorescence Immunoassays (FIA) market estimates and forecast, 2018 - 2030
  • Fig. 26 Radioimmunoassay market estimates and forecast, 2018 - 2030
  • Fig. 27 Enzyme-Linked Immunoassay market estimates and forecast, 2018 - 2030
  • Fig. 28 Consumables and Accessories market estimates and forecast, 2018 - 2030
  • Fig. 29 Immunoassay analyzers Market: Application movement analysis
  • Fig. 30 Immunoassay analyzers market: Application outlook and key takeaways
  • Fig. 31 Therapeutic drug monitoring market estimates and forecasts, 2018 - 2030
  • Fig. 32 Oncology market estimates and forecasts, 2018 - 2030
  • Fig. 33 Cardiology market estimates and forecasts, 2018 - 2030
  • Fig. 34 Endocrinology market estimates and forecasts, 2018 - 2030
  • Fig. 35 Infectious disease testing market estimates and forecasts, 2018 - 2030
  • Fig. 36 Autoimmune disease market estimates and forecasts, 2018 - 2030
  • Fig. 37 Others market estimates and forecasts, 2018 - 2030
  • Fig. 38 Immunoassay analyzers market: End use movement analysis
  • Fig. 39 Immunoassay analyzers market: End- use outlook and key takeaways
  • Fig. 40 Hospitals & clinics market estimates and forecasts, 2018 - 2030
  • Fig. 41 Diagnostic laboratories market estimates and forecasts, 2018 - 2030
  • Fig. 42 Research Institutes market estimates and forecasts, 2018 - 2030
  • Fig. 43 Global immunoassay analyzers market: Regional movement analysis
  • Fig. 44 Global immunoassay analyzers market: Regional outlook and key takeaways
  • Fig. 45 Global immunoassay analyzers market share and leading players
  • Fig. 46 North America market share and leading players
  • Fig. 47 Europe market share and leading players
  • Fig. 48 Asia Pacific market share and leading players
  • Fig. 49 Latin America market share and leading players
  • Fig. 50 Middle East & Africa market share and leading players
  • Fig. 51 North America: SWOT
  • Fig. 52 Europe SWOT
  • Fig. 53 Asia Pacific SWOT
  • Fig. 54 Latin America SWOT
  • Fig. 55 MEA SWOT
  • Fig. 56 North America, by country
  • Fig. 57 North America
  • Fig. 58 North America market estimates and forecasts, 2018 - 2030
  • Fig. 59 U.S.
  • Fig. 60 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 61 Canada
  • Fig. 62 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 63 Mexico
  • Fig. 64 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 65 Europe
  • Fig. 66 Europe market estimates and forecasts, 2018 - 2030
  • Fig. 67 UK
  • Fig. 68 UK market estimates and forecasts, 2018 - 2030
  • Fig. 69 Germany
  • Fig. 70 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 71 France
  • Fig. 72 France market estimates and forecasts, 2018 - 2030
  • Fig. 73 Italy
  • Fig. 74 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 75 Spain
  • Fig. 76 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 77 Denmark
  • Fig. 78 Denmark market estimates and forecasts, 2018 - 2030
  • Fig. 79 Sweden
  • Fig. 80 Sweden market estimates and forecasts, 2018 - 2030
  • Fig. 81 Norway
  • Fig. 82 Norway market estimates and forecasts, 2018 - 2030
  • Fig. 83 Asia Pacific
  • Fig. 84 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 85 China
  • Fig. 86 China market estimates and forecasts, 2018 - 2030
  • Fig. 87 Japan
  • Fig. 88 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 89 India
  • Fig. 90 India market estimates and forecasts, 2018 - 2030
  • Fig. 91 Thailand
  • Fig. 92 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 93 South Korea
  • Fig. 94 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 95 Australia
  • Fig. 96 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 97 Latin America
  • Fig. 98 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 99 Brazil
  • Fig. 100 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 101 Argentina
  • Fig. 102 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 103 Middle East and Africa
  • Fig. 104 Middle East and Africa market estimates and forecasts, 2018 - 2030
  • Fig. 105 South Africa
  • Fig. 106 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 107 Saudi Arabia
  • Fig. 108 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 109 UAE
  • Fig. 110 UAE market estimates and forecasts, 2018 - 2030
  • Fig. 111 Kuwait
  • Fig. 112 Kuwait market estimates and forecasts, 2018 - 2030
  • Fig. 113 Market share of key market players- Immunoassay analyzers market
目次
Product Code: GVR-1-68038-992-0

Immunoassay Analyzers Market Trends:

The global Immunoassay analyzers market size was estimated at USD 7.18 billion in 2024 and is expected to grow at a CAGR of 4.13% from 2025 to 2030. The increasing prevalence of chronic diseases, including both infectious and non-infectious conditions, is a significant driver of market growth for immunoassay analyzers. As the burden of diseases such as cancer and cardiovascular conditions continues to rise, technological advancements and the application of immunoassay analyzers are expanding rapidly. These advancements play a crucial role in early diagnosis, disease monitoring, and treatment planning. The World Health Organization (WHO) reported approximately 20 million new cancer cases in 2022, with a projected increase in diagnoses reaching 53.5 million in the coming years. This surge in chronic illnesses is fueling the demand for innovative immunoassay solutions, leading companies to develop more advanced and effective diagnostic technologies.

The outbreak of the COVID-19 pandemic further emphasized the need for rapid and accurate diagnostic tools. The emergence of the SARS-CoV-2 virus created an urgent demand for accelerated diagnostic methods that could offer both precision and affordability. While RT-PCR tests were widely used for early detection, they were often considered expensive and resource-intensive. This led to the widespread deployment of immunoassay analyzers for detecting antibodies, providing a more cost-effective and efficient alternative. Companies responded swiftly to this demand by launching advanced immunoassay solutions. For instance, Agilent Technologies, Inc. introduced the Agilent Dako SARS-CoV-2 enzyme-linked immunoassay kit, designed to detect SARS-CoV-2 antibodies in human serum or plasma. The pandemic heightened awareness about the capabilities of immunoassay analyzers, accelerating technological developments and market expansion.

The increasing prevalence of chronic diseases has driven continuous advancements in immunoassay technologies. The emergence of new infectious diseases, growing concerns over antibiotic resistance, and the rising demand for personalized medicine have spurred the need for highly sensitive, specific, and rapid immunoassay tests. Various companies are investing in innovative solutions to meet these evolving healthcare needs. Diamond Diagnostics, for example, is committed to enhancing immunoassay diagnostics by manufacturing high-quality, cost-effective consumables and accessories for immunoassay analyzers. Such innovations contribute to the expansion of the market, ensuring that healthcare providers have access to reliable and advanced diagnostic tools.

In addition to technological advancements, strategic collaborations among key industry players are significantly contributing to market growth. Companies are increasingly forming partnerships to strengthen their immunoassay capabilities, support therapeutic advancements, and facilitate clinical adoption. A notable example is the collaboration between Beckman Coulter, Inc. and Fujirebio in July 2023. This partnership aims to enhance immunoassay applications in neurodegenerative disease research, clinical trials, routine diagnostics, and reimbursement processes. By combining expertise and resources, these collaborations are driving innovation and improving the accessibility of advanced diagnostic solutions.

Global Immunoassay Analyzers Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For the purpose of this study, Grand View Research has segmented the global Immunoassay analyzers market report on the basis of product, application, end use, region:

  • Product Outlook (Revenue, USD Million, 2018 - 2030)
  • Chemiluminescence Immunoassays (CLIA)
  • Fluorescence Immunoassays (FIA)
  • Radioimmunoassay
  • Enzyme-Linked Immunoassay
  • Consumables and Accessories
  • Application Outlook (Revenue, USD Million, 2018 - 2030)
  • Therapeutic Drug Monitoring
  • Oncology
  • Cardiology
  • Endocrinology
  • Infectious Disease Testing
  • Autoimmune Disease
  • Others
  • End-use Outlook (Revenue, USD Million, 2018 - 2030)
  • Hospitals & Clinics
  • Diagnostic Laboratories
  • Research Institutes
  • Regional Outlook (Revenue in USD Million, 2018 - 2030)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Sweden
    • Denmark
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa
    • Saudi Arabia
    • South Africa
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Application
    • 1.2.3. End Use
    • 1.2.4. Regional scope
    • 1.2.5. Estimates and forecasts timeline.
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Application outlook
    • 2.2.3. End Use outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Immunoassay Analyzers Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rising Prevalence of chronic and infectious diseases
      • 3.2.1.2. Technological advancements
      • 3.2.1.3. Growing adoption of personalized products
      • 3.2.1.4. Growing investments and collaborations
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High costs and operational complexity
  • 3.3. Immunoassay Analyzers Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis
  • 3.4. Case Study

Chapter 4. Immunoassay Analyzers Market: Product Estimates & Trend Analysis

  • 4.1. Products Market Share, 2024 & 2030
  • 4.2. Segment Dashboard
  • 4.3. Immunoassay Analyzers Market: Product Movement Analysis
  • 4.4. Immunoassay Analyzers Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 4.5. Chemiluminescence Immunoassays (CLIA)
    • 4.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Fluorescence Immunoassays (FIA)
    • 4.6.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.7. Radioimmunoassay
    • 4.7.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.8. Enzyme-Linked Immunoassay
    • 4.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.9. vConsumables and Accessories
    • 4.9.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.10. Consumables and Accessories
    • 4.10.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Immunoassay Analyzers Market: Application Estimates & Trend Analysis

  • 5.1. Application Market Share, 2024 & 2030
  • 5.2. Segment Dashboard
  • 5.3. Global Immunoassay Analyzers Market by Application Outlook
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 5.5. Therapeutic Drug Monitoring
    • 5.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. Oncology
    • 5.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.7. Cardiology
    • 5.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.8. Endocrinology
    • 5.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.9. Infectious Disease Testing
    • 5.9.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.10. Autoimmune Disease
    • 5.10.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.11. Others
    • 5.11.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Immunoassay Analyzers Market: End Use Estimates & Trend Analysis

  • 6.1. End Use Market Share, 2024 & 2030
  • 6.2. Segment Dashboard
  • 6.3. Global Immunoassay Analyzers Market by End Use Outlook
  • 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 6.5. Hospitals & Clinics
    • 6.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Diagnostic Laboratories
    • 6.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7. Research Institutes
    • 6.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Immunoassay Analyzers Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2024 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Global Regional Market Snapshot
  • 7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 7.5. North America
    • 7.5.1. North America: SWOT Analysis
    • 7.5.2. U.S.
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework/Reimbursement
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.3. Canada
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework/Reimbursement
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.4. Mexico
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Regulatory framework/Reimbursement
      • 7.5.4.3. Competitive scenario
      • 7.5.4.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Europe
    • 7.6.1. Europe: SWOT Analysis
    • 7.6.2. UK
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework/Reimbursement
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.3. Germany
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Regulatory framework/Reimbursement
      • 7.6.3.3. Competitive scenario
      • 7.6.3.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.4. France
      • 7.6.4.1. Key country dynamics
      • 7.6.4.2. Regulatory framework/Reimbursement
      • 7.6.4.3. Competitive scenario
      • 7.6.4.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.5. Italy
      • 7.6.5.1. Key country dynamics
      • 7.6.5.2. Regulatory framework/Reimbursement
      • 7.6.5.3. Competitive scenario
      • 7.6.5.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.6. Spain
      • 7.6.6.1. Key country dynamics
      • 7.6.6.2. Regulatory framework/Reimbursement
      • 7.6.6.3. Competitive scenario
      • 7.6.6.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.7. Norway
      • 7.6.7.1. Key country dynamics
      • 7.6.7.2. Regulatory framework/Reimbursement
      • 7.6.7.3. Competitive scenario
      • 7.6.7.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.8. Sweden
      • 7.6.8.1. Key country dynamics
      • 7.6.8.2. Regulatory framework/Reimbursement
      • 7.6.8.3. Competitive scenario
      • 7.6.8.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.9. Denmark
      • 7.6.9.1. Key country dynamics
      • 7.6.9.2. Regulatory framework/Reimbursement
      • 7.6.9.3. Competitive scenario
      • 7.6.9.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7. Asia Pacific
    • 7.7.1. Asia Pacific: SWOT Analysis
    • 7.7.2. Japan
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework/Reimbursement
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.3. China
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework/Reimbursement
      • 7.7.3.3. Competitive scenario
      • 7.7.3.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.4. India
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Regulatory framework/Reimbursement
      • 7.7.4.3. Competitive scenario
      • 7.7.4.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.5. Australia
      • 7.7.5.1. Key country dynamics
      • 7.7.5.2. Regulatory framework/Reimbursement
      • 7.7.5.3. Competitive scenario
      • 7.7.5.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.6. South Korea
      • 7.7.6.1. Key country dynamics
      • 7.7.6.2. Regulatory framework/Reimbursement
      • 7.7.6.3. Competitive scenario
      • 7.7.6.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.7. Thailand
      • 7.7.7.1. Key country dynamics
      • 7.7.7.2. Regulatory framework/Reimbursement
      • 7.7.7.3. Competitive scenario
      • 7.7.7.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.8. Latin America
    • 7.8.1. Latin America: SWOT Analysis
    • 7.8.2. Brazil
      • 7.8.2.1. Key country dynamics
      • 7.8.2.2. Regulatory framework/Reimbursement
      • 7.8.2.3. Competitive scenario
      • 7.8.2.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.8.3. Argentina
      • 7.8.3.1. Key country dynamics
      • 7.8.3.2. Regulatory framework/Reimbursement
      • 7.8.3.3. Competitive scenario
      • 7.8.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.9. MEA
    • 7.9.1. MEA: SWOT Analysis
    • 7.9.2. South Africa
      • 7.9.2.1. Key country dynamics
      • 7.9.2.2. Regulatory framework/Reimbursement
      • 7.9.2.3. Competitive scenario
      • 7.9.2.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.9.3. Saudi Arabia
      • 7.9.3.1. Key country dynamics
      • 7.9.3.2. Regulatory framework/Reimbursement
      • 7.9.3.3. Competitive scenario
      • 7.9.3.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.9.4. UAE
      • 7.9.4.1. Key country dynamics
      • 7.9.4.2. Regulatory framework/Reimbursement
      • 7.9.4.3. Competitive scenario
      • 7.9.4.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.9.5. Kuwait
      • 7.9.5.1. Key country dynamics
      • 7.9.5.2. Regulatory framework
      • 7.9.5.3. Competitive scenario
      • 7.9.5.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
  • 8.3. Vendor Landscape
    • 8.3.1. List of key distributors and channel partners
    • 8.3.2. Key customers
    • 8.3.3. Key company market share analysis, 2024
    • 8.3.4. Siemens Healthineers AG
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Services benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. BIOMERIEUX
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Services benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. FAbbott
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Services benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. QuidelOrtho Corporation
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Services benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. Sysmex Corporation
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Services benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. BD
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Services benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. Thermo Fisher Scientific Inc.
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Services benchmarking
      • 8.3.10.4. Strategic initiatives
    • 8.3.11. F. Hoffmann-La Roche Ltd
      • 8.3.11.1. Company overview
      • 8.3.11.2. Financial performance
      • 8.3.11.3. Services benchmarking
      • 8.3.11.4. Strategic initiatives
    • 8.3.12. Beckman Coulter, Inc.
      • 8.3.12.1. Company overview
      • 8.3.12.2. Financial performance
      • 8.3.12.3. Services benchmarking
      • 8.3.12.4. Strategic initiatives
    • 8.3.13. DiaSorin S.p.A.
      • 8.3.13.1. Company overview
      • 8.3.13.2. Financial performance
      • 8.3.13.3. Services benchmarking
      • 8.3.13.4. Strategic initiatives